TITLE

Better Reviews, Great Results

AUTHOR(S)
Wiscombe, Janet
PUB. DATE
November 2001
SOURCE
Workforce;Nov2001, Vol. 80 Issue 11, p16
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on the performance appraisal approach of Bristol-Myers Squibb Co. with the help of Applied Psychological Techniques Incorporated. Problems with Bristol-Myers' former performance appraisal system; Benefits of the performance appraisal system developed by Applied Psychological Techniques for Bristol-Myers.
ACCESSION #
5497518

 

Related Articles

  • Norms for Performance in the Workplace in Healthy People: Data from the National Comorbidity Survey Replication Study. Deckersbach, Thilo; Stange, Jonathan P.; Nierenberg, Andrew A. // CNS Spectrums: The International Journal of Neuropsychiatric Med;Jul2011, p1 

    Introduction: Psychiatric conditions affect multiple areas of psychosocial functioning, including functioning in the workplace. The purpose of this study was to establish norms for absenteeism (work days missed due to mental or physical illness) and work performance (quality of work performed...

  • New management.  // Crain's New York Business;11/16/98, Vol. 14 Issue 46, p62 

    Focuses on changes in the management structure of Bristol-Myers Squibb Co.

  • Consumers targeted by Capoten promo.  // Drug Topics;9/5/94, Vol. 138 Issue 17, p8 

    Reports that Bristol-Myers Squibb has enlisted chain pharmacies in its first direct-to-consumer marketing campaign.

  • A hard one to swallow.  // Drug Topics;11/7/94, Vol. 138 Issue 21, p7 

    Reports that Bristol-Myers Squibb is withdrawing Questran tablets from the market after a patient choked on the large tablet.

  • Labelers glide along smoothly for Bristol-Myers' ban. Hartman, Lauren R. // Packaging Digest;Sep97, Vol. 34 Issue 10, p84 

    Focuses on the packaging of the Ban, clear soft solid antiperspirant/deodorant, by Bristol-Myers Squibb. Comments from Ken Laing, senior project engineering manager at Bristol-Myers; What discovery did Laing make; Description of the features of this product.

  • Bristol-Myers shakeup.  // Chemical Week;1/5/1994-1/12/1994, Vol. 154 Issue 1, p8 

    Reports on the labor shakeup plans of drugs group Bristol-Myers Squibb. Reduction of 5,000 jobs; Restructuring of sales and marketing operations.

  • Untitled.  // Broadcasting & Cable;4/26/93, Vol. 123 Issue 17, p81 

    Reports on Bristol-Myers Squibb's producing of a new half-hour prime time anthology series for Lifetime. Debut of `Amazing Love Stories' in October on the network; 13-episode series.

  • Bristol mulls selling Clairol, Ban lines. Sloan, Pat // Advertising Age;3/8/1993, Vol. 64 Issue 10, p2 

    Reports that Bristol-Myers Squibb Co. is considering selling its Clairol division as well as the Ban deodorant and Keri skincare lines. Leading marketers said to be interested in acquisition including Colgate-Palmolive Co.; Sale of the Clairol, Ban and Keri lines would effectively take the...

  • BMS shops $20 Mil. account. Kim, Hank; Comiteau, Jennifer // Adweek Western Edition;11/03/97, Vol. 47 Issue 44, p67 

    States that Bristol-Myers Squibb company (BMS) has contacted at least one agency in relation to its $20 million Vagistat-1 account. Details on the account being at Wells BDDP; Why BMS contacted the agency.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics